drugset / Trial / NCT00004730
Magnesium Sulfate For Brain Injury
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to determine whether magnesium sulfate, given within 8 hours of a moderate or severe traumatic brain injury improves survival, decreases the number of people developing seizures, improves the survivors' mental and psychological functioning, including the ability to return to daily life, live independently, and return to work or school.
Timeline
- Start
- 1998-08
- Primary completion
- 2005-05
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Magnesium Sulfate | Other / unclassified | 0.24 unknown | Intravenous |